Recursion Pharmaceuticals
RXRX
$8.51
Share price
-5.55%
Change (1 day)
-6.17%
Change (1 year)
Categories
Recursion Pharmaceuticals (RXRX) - P/B ratio
P/B ratio as of June 2024 : 5.17
According to Recursion Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 5.17.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Recursion Pharmaceuticals - P/B ratio (from 2021 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 4.59 | 52.67% |
| 2022-12-31 | 3.01 | -43.58% |
| 2021-12-31 | 5.33 | |
| 2020-12-31 | N/A |